HIGHLIGHTS
- who: Report and colleagues from the (UNIVERSITY) have published the research work: Review began 02/09/2023 Review ended 03/07/2023 Published 03/09/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/09,/2023
- what: While FSRT has shown encouraging results in preventing brain RN, the authors report a case of RN in a patient with ALK-rearranged NSCLC despite FSRT, one year after the completion of radiotherapy while on alectinib.
SUMMARY
In patients with ALK-positive NSCLC, more than 50% may develop brain metastases during their disease course . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.